Funded Startups in Abingdon
Abingdon, a market town in Oxfordshire roughly 60 miles northwest of London, has generated funded ventures across hardware, life sciences, data analytics,…
Abingdon, a market town in Oxfordshire roughly 60 miles northwest of London, has generated funded ventures across hardware, life sciences, data analytics, and agriculture. The 10 most recent rounds in this listing span from Summit Therapeutics' $75M close in May 2021 through to EnSilica's $13M raise in February 2025. The largest single round visible here is Nexeon's $90M Series D from August 2022, a consumer electronics company working in battery materials. Biotechnology contributes two entries — Orthox Ltd at $12M Series A and Summit Therapeutics at $75M — while Sense Biodetection rounds out the life sciences cluster with a $15M Series B in November 2021.
Not all rounds are conventional equity: Oxitec received an $18M grant in April 2022 for agricultural work, and P2i closed an $8M private equity round in December 2021. Several companies carry undisclosed amounts or are classified as Series Unknown, reflecting the opacity typical of UK private markets. BelleVie's $2M Seed in December 2022 marks the smallest disclosed raise in the set.
Most recent rounds
10 shownRelated listings
Frequently asked
What are the largest disclosed rounds among Abingdon startups in this dataset?
Nexeon leads with a $90M Series D closed in August 2022, followed by Summit Therapeutics at $75M in May 2021 and Intralink at $25M in July 2023. These three rounds alone account for the majority of disclosed capital across the 10 companies shown.
Which sectors appear most frequently in Abingdon's recent funding activity?
Hardware and Biotechnology each have two entries: EnSilica and Infinitesima Ltd in hardware, and Orthox Ltd and Summit Therapeutics in biotech. Life sciences more broadly — adding Sense Biodetection in health care — represents three of the 10 companies shown.
What is the most recent funding event listed for an Abingdon company?
EnSilica's $13M Series Unknown round, dated February 3, 2025, is the most recent in this dataset. The next most recent is Intralink's $25M raise in July 2023, leaving a roughly 18-month gap between those two events.
Are there any Abingdon companies that raised outside of traditional equity rounds?
Oxitec received an $18M grant in April 2022 for its agriculture and farming work, and P2i closed an $8M private equity round in December 2021. Both sit outside the standard seed-to-Series progression.
How wide is the stage distribution across these 10 companies?
Stages range from Seed — BelleVie's $2M round in December 2022 — up to Series D, represented by Nexeon's $90M raise. Several companies are listed as Series Unknown or carry undisclosed amounts, which is common for UK private rounds.
Which Abingdon companies are most relevant for sales teams targeting the life sciences vertical?
Sense Biodetection (Series B, $15M, November 2021), Orthox Ltd (Series A, $12M, February 2022), and Summit Therapeutics ($75M, May 2021) are the three life sciences-adjacent entries in this dataset, spanning health care and biotechnology.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.